Canbex Therapeutics canbex.co.uk


Public lists: Pharma Startups (4732)

Canbex Therapeutics is dedicated to treating spasticity in multiple sclerosis (MS) and potentially other disorders. Spasticity is a debilitating and painful symptom of MS that consists of involuntary spasms of limbs and torso. The goal of the Canbex lead programme is to set a new standard in the treatment of spasticity, through improved tolerability. The company's lead compound, VSN16R, is currently in Phase I human safety trials.

Canbex Therapeutics is dedicated to treating spasticity in multiple sclerosis (MS) and potentially other disorders. Spasticity is a debilitating and painful symptom of MS that consists of involuntary spasms of limbs and torso. The goal of the Canbex ...Show all

Company (Acquired)

Phone: +44(0)20-7554-5872

Fax:

2 Royal College Street

London, NW1 0NH
England, United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Canbex Therapeutics $4.7M Feb 24, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Canbex Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Benzamide derivatives useful in the treatment of muscular disorders and pain and for controlling spasticity and tremors Dec 05, 2014 Mar 06, 2018 Patent
Crystalline form of vsn16 Jan 17, 2014 Jun 20, 2017 Patent
Modulator Oct 18, 2012 Sep 01, 2015 Patent
Compounds for treating disorders associated with bk channel modulation Feb 12, 2016 Application
Bkca channel activator for treating muscular disorder Feb 12, 2016 Application
See all 6 patents